Literature DB >> 33737705

Correlation between family history and characteristics of breast cancer.

Lei Liu1,2,3,4, Xiaomeng Hao1,2,3,4, Zian Song1,2,3,4, Xiangcheng Zhi1,2,3,4, Sheng Zhang1,2,3,4, Jin Zhang5,6,7,8.   

Abstract

Family history is a major risk factor for breast cancer; approximately 5-10% cases of breast cancer are associated with a family history. Herein, we investigated the link between family history and breast cancer features to elucidate the importance of family history in the diagnosis and treatment of breast cancer. Data from 10,549 patients with breast cancer were collected from 2014 to 2017. Detailed information about the family history of the patients including the degree and number of relatives affected and the types of cancer was recorded. The tumors were pathologically and clinically classified based on the stage, grade, ER, PR, HER2, Ki-67 status, and subtypes, according to standard guidelines. Data were analyzed using χ2 test and multiple logistic regression. Patients with a family history of other cancer types were significantly older at diagnosis than patients with a family history of breast/ovarian cancer (p = 0.002) and those without a family history of cancer (p < 0.001). Patients without a family history of cancer were typically diagnosed at a later stage, including high frequency in N2 (p = 0.035) and TNM stage III (p = 0.015). Compared with patients with second-/third-degree relatives, those with first-degree relatives having breast/ovarian cancer had a higher median age (54.1, p < 0.001) at diagnosis and showed more advanced disease. No significant difference was found between ER, PR, and HER2 status in patients with and without a family history of cancer. Family history of breast cancer can influence the cancer characteristics of the patients at diagnosis, especially patient age, tumor stage, and grade.

Entities:  

Year:  2021        PMID: 33737705     DOI: 10.1038/s41598-021-85899-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  26 in total

Review 1.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

Review 2.  ATM Mutations in Cancer: Therapeutic Implications.

Authors:  Michael Choi; Thomas Kipps; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2016-07-13       Impact factor: 6.261

3.  Women's Health Issues for BRCA Mutation Carriers.

Authors:  Mary E Sabatini; Leif W Ellisen
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

4.  Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care.

Authors:  Ella R Thompson; Simone M Rowley; Na Li; Simone McInerny; Lisa Devereux; Michelle W Wong-Brown; Alison H Trainer; Gillian Mitchell; Rodney J Scott; Paul A James; Ian G Campbell
Journal:  J Clin Oncol       Date:  2016-01-19       Impact factor: 44.544

5.  Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations.

Authors:  Holly L Howe; Xiaocheng Wu; Lynn A G Ries; Vilma Cokkinides; Faruque Ahmed; Ahmedin Jemal; Barry Miller; Melanie Williams; Elizabeth Ward; Phyllis A Wingo; Amelie Ramirez; Brenda K Edwards
Journal:  Cancer       Date:  2006-10-15       Impact factor: 6.860

6.  Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.

Authors:  Jacqueline Mersch; Michelle A Jackson; Minjeong Park; Denise Nebgen; Susan K Peterson; Claire Singletary; Banu K Arun; Jennifer K Litton
Journal:  Cancer       Date:  2014-09-15       Impact factor: 6.860

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  Family history and risk of breast cancer: an analysis accounting for family structure.

Authors:  Hannah R Brewer; Michael E Jones; Minouk J Schoemaker; Alan Ashworth; Anthony J Swerdlow
Journal:  Breast Cancer Res Treat       Date:  2017-06-03       Impact factor: 4.872

9.  Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.

Authors:  Shuting Li; Yanwei Shen; Mengying Wang; Jiao Yang; Meng Lv; Pan Li; Zheling Chen; Jin Yang
Journal:  Oncotarget       Date:  2017-05-09

10.  Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer.

Authors:  Natalie J Engmann; Marzieh K Golmakani; Diana L Miglioretti; Brian L Sprague; Karla Kerlikowske
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

View more
  5 in total

Review 1.  Breast Cancer Genomics: Primary and Most Common Metastases.

Authors:  Caroline Bennett; Caleb Carroll; Cooper Wright; Barbara Awad; Jeong Mi Park; Meagan Farmer; Elizabeth Bryce Brown; Alexis Heatherly; Stefanie Woodard
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

2.  Cancers preventive practice and the determinants in Amhara regional state, Northwest Ethiopia.

Authors:  Getasew Mulat Bantie; Koku Sisay Tamirat; Ashenafi Abate Woya; Amare Alemu Melese; Agumas Fentahun Ayalew; Gizachew Asmare Wubetu; Gizachew Tadesse Wassie; Kalkidan Worku Mitiku; Minichil Genet Minale; Amanuel Addisu Dessie; Selam Fisiha Kassa; Girum Meseret Ayenew
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

3.  Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?

Authors:  Alessandro Lavoro; Aurora Scalisi; Saverio Candido; Guido Nicola Zanghì; Roberta Rizzo; Giuseppe Gattuso; Giuseppe Caruso; Massimo Libra; Luca Falzone
Journal:  Int J Oncol       Date:  2022-04-06       Impact factor: 5.650

4.  Diagnostic value of radiomics model based on gray-scale and contrast-enhanced ultrasound for inflammatory mass stage periductal mastitis/duct ectasia.

Authors:  Yan Zheng; Lu Bai; Jie Sun; Lin Zhu; Renjun Huang; Shaofeng Duan; Fenglin Dong; Zaixiang Tang; Yonggang Li
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

5.  Evaluation of the Clinical and Imaging Findings of Breast Examinations in a Tertiary Facility in Ghana.

Authors:  Emmanuel Kobina Mesi Edzie; Klenam Dzefi-Tettey; Philip Narteh Gorleku; Adu Tutu Amankwa; Eric Aidoo; Kwasi Agyen-Mensah; Ewurama Andam Idun; Frank Quarshie; Joshua Mensah Kpobi; Henry Kusodzi; Richard Ato Edzie; Abdul Raman Asemah
Journal:  Int J Breast Cancer       Date:  2021-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.